News and Announcements
Bulletproof Group Appoints New Company Secretary & COO Update
- Published June 01, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Bulletproof Group Limited (ASX:BPF) (Bulletproof) wishes to advise that Company Secretary, Ms. Kylie Turner, will be stepping down from her role effective 2 June 2017. Ms. Paula Kensington, appointed Bulletproof CFO on 1 May 2017 (refer ASX release 21 April 2017 for background) and Mr. Damien Connor have been appointed as joint company secretaries to replace Ms. Turner.
Mr. Connor is an experienced ASX listed company secretary acting in this capacity for Sundance Energy Australia Limited, Archer Exploration Limited and UraniamSA Limited. He is a Chartered Accountant, Graduate of AICD and a member of Governance Institute of Australia. Previous employers include Heathgate Resources and PricewaterhouseCoopers.
The board, management and staff at Bulletproof wish Ms. Turner all the very best in her employment and other ventures moving forward.
The company also wishes to advise that following the resignation of Mr. Mark Rainbird as the company’s COO in March 2017, a search for a suitably qualified replacement has commenced, targeting a start date for a successful candidate in the early part of FY18.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
